Zenith Epigenetics Ltd.
Records under this name other than the patents Zenith Epigenetics Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Back to Zenith Epigenetics Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,855,271 | Quinazolinones as bromodomain inhibitors Lapsed on the fee record Ended Jan 2, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 2, 2026 | From the USPTO record |
| US 11,026,926 | Substituted bicyclic compounds as bromodomain inhibitors Lapsed on the fee record Ended Jun 8, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 8, 2025 | From the USPTO record |
| US 9,662,311 | Substituted bicyclic compounds as bromodomain inhibitors Lapsed on the fee record Ended May 30, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 30, 2025 | From the USPTO record |
| US 9,636,328 | Substituted bicyclic compounds as bromodomain inhibitors Lapsed on the fee record Ended May 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 2, 2025 | From the USPTO record |
| US 10,710,992 | Substituted pyridinones as bromodomain inhibitors Lapsed on the fee record Ended Jul 14, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 14, 2024 | From the USPTO record |
| US 9,278,940 | Cyclic amines as bromodomain inhibitors Lapsed on the fee record Ended Mar 8, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 8, 2024 | From the USPTO record |
| US 9,271,978 | Heterocyclic compounds as bromodomain inhibitors Lapsed on the fee record Ended Mar 1, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 1, 2024 | From the USPTO record |
| US 10,500,209 | Quinazolinones as bromodomain inhibitors Lapsed on the fee record Ended Dec 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2023 | From the USPTO record |
| US 9,073,878 | Cyclic amines as bromodomain inhibitors Lapsed on the fee record Ended Jul 7, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 7, 2023 | From the USPTO record |
| US 10,292,968 | Substituted heterocycles as bromodomain inhibitors Lapsed on the fee record Ended May 21, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 21, 2023 | From the USPTO record |